Time-dependent impact of immunosuppressant regimens on cardiovascular outcomes in kidney transplant recipients: a nationwide cohort study

Time-dependent impact of immunosuppressant regimens on cardiovascular outcomes in kidney transplant recipients: a nationwide cohort study

ObjectivesWe aimed to evaluate the effect of different immunosuppressive regimens on the risk of major adverse cardiovascular events (MACEs) in kidney transplant recipients (KTRs).MethodsThis retrospective cohort study used nationwide claims data from the Korean Health Insurance Review and Assessmen...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jinhyun Park, Wonhui Choi, Jinseub Hwang, Young-Mi Ah, Byung Ha Chung, Yun-Kyoung Song
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Pharmacology
Subjects:	kidney transplantation immunosuppressive agents cardiovascular outcomes comorbidity time-dependent analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1540576/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Histopathological analysis of the skin of renal transplant recipients submitted to three different immunosuppression regimens
by: Maria Victória Quaresma, et al.
Published: (2025-08-01)

Adverse effects of immunosuppressive therapy after kidney transplant
by: S. V. Popov, et al.
Published: (2025-03-01)

Comparative analysis of induction immunosuppressive therapy protocols in renal transplant recipients (retrospective review)
by: Sh. R. Galeev, et al.
Published: (2020-07-01)

Immunosuppressive therapy in non-infections uveitis and retinovasculitis
by: E. A. Drozdova
Published: (2014-07-01)

Modification of immunosuppressive agents in a kidney transplant recipient with COVID-19 and acute kidney injury
by: Thanawat Vongchaiudomchoke, et al.
Published: (2021-09-01)

A novel conditioning regimen with pre-transplantation immunosuppression reduces the complication rates in hematopoietic stem cell transplantation in transfusion-dependent β-thalassemia
by: Huaqing Yang, et al.
Published: (2024-12-01)

A national survey of immunosuppression adjustment in elderly lung transplant recipients
by: Jade M Kozuch, et al.
Published: (2024-12-01)

Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients
by: M. Sh Khubutia, et al.
Published: (2016-01-01)

Polypharmacy, therapeutic inertia, and adherence of heart recipients to drug therapy
by: I. I. Muminov, et al.
Published: (2025-01-01)

Evaluation of Anxiety, Self-Management and Compliance with Immunosuppressive Therapy in Kidney Transplant Recipients
by: Aliye Bulut, et al.
Published: (2025-06-01)

Сlinical features of malignant tumors against the background of immunosuppressive therapy in heart transplant recipients
by: L. B. Krougly, et al.
Published: (2021-07-01)

Varicella and Zoster Vaccination Strategies in Immunosuppressed Pediatric Transplant Recipients
by: Christopher Hartley, et al.
Published: (2025-05-01)

Comparison of quality of life in patients after kidney transplantation under different regimens of immunosuppressive therapy
by: E. V. Parabina, et al.
Published: (2025-01-01)

Interactions between Immunosuppressive Therapy and Direct-Acting Antivirals in Kidney Transplant Recipient with Hepatitis C Infection
by: Paolo Carta, et al.
Published: (2020-05-01)

Squamous cell carcinoma in a kidney transplant recipient after 26 years
by: Carolina da Silva Nunes, et al.
Published: (2024-03-01)

Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study
by: Soo-Kyung Cho, et al.
Published: (2025-01-01)

Impact of immunosuppressive therapy on pulmonary perfusion in kidney transplant recipients after COVID-19 illness
by: Barbara Infante, et al.
Published: (2025-06-01)

Investigation of immunosuppressive treatment compliance, dyspnea, anxiety, and depression levels in lung transplant recipients: online interview
by: Semra Bulbuloglu, et al.
Published: (2024-10-01)

Immunosuppression Management in Heart Transplantation
by: Marlena Habal
Published: (2025-05-01)

Induction immunosuppression in kidney transplantation: Thymoglobulin® (a literature review)
by: A. V. Pinchuk
Published: (2016-02-01)

Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients
by: Eman H Ibrahim, et al.
Published: (2021-12-01)

Fecal microbiota transplantation alleviates immunosuppressant-associated diarrhea and recurrent urinary tract infection in kidney transplant recipients: a retrospective analysis
by: Jianmin Hu, et al.
Published: (2025-05-01)

Risk Prediction and Management of BKPyV-DNAemia in Kidney Transplant Recipients: A Multicenter Analysis of Immunosuppressive Strategies
by: Jin-Myung Kim, et al.
Published: (2025-07-01)

Relevance of Tacrolimus Trough Concentration and Hepatitis E virus Genetic Changes in Kidney Transplant Recipients With Chronic Hepatitis E
by: Nancy León-Janampa, et al.
Published: (2024-05-01)

Pharmacoeconomic analysis of everolimus immunosuppressive therapy for <i>de novo</i> kidney transplant recipients in Russia
by: N. A. Avxentyev, et al.
Published: (2019-05-01)

Clinical laboratory aspects of one-component immunosuppression during liver transplantation
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)

Immunosenescence as a reason of individualizing immunosuppressive therapy in kidney transplantation
by: V. A. Fedulkina, et al.
Published: (2021-09-01)

Gagam-Palmultang Restores Immune Homeostasis and T Lymphocyte Activation in a Cyclophosphamide-Induced Immunosuppression Mouse Model
by: Jin Young Hong, et al.
Published: (2025-03-01)

Transplant oncology and anti-cancer immunosuppressants
by: Dejun Kong, et al.
Published: (2025-01-01)

The basic principles of immunosuppressive therapy after kidney transplantation
by: D. N. Suslov
Published: (2018-03-01)

Evaluation of the results of treatment of kidney recipients at the outpatient stage against the background of minimizing immunosuppressive therapy
by: E. V. Parabina, et al.
Published: (2023-10-01)

Clinical profile, response and outcome of various immunosuppressive regimens used for treatment of idiopathic membranous nephropathy—a retrospective cohort study
by: Megha Saigal, et al.
Published: (2024-12-01)

The choice of immunosuppressive therapy depending on the level of anti-HLA antibodies in kidney transplantation
by: N. V. Borovkova, et al.
Published: (2018-03-01)

Early neonatal outcomes in infants of mothers with organ transplantation under immunosuppressive treatment
by: Kıymet Çelik, et al.
Published: (2024-02-01)

A population-based analysis of immunosuppression therapy after organ transplantation
by: Franziska Hörbrand, et al.
Published: (2025-05-01)

Risks and ways of preventing kidney dysfunction in drug-induced immunosuppression in solid organ recipients
by: Sh. R. Galeev, et al.
Published: (2022-12-01)

THE INDIVIDUAL TAILORING OF IMMUNOSUPPRESSIVE THERAPY AFTER HEART TRANSPLANTATION
by: N. N. Koloskova, et al.
Published: (2018-04-01)

The Evolution of Immunosuppressive Therapy in Pig-to-Nonhuman Primate Organ Transplantation
by: S. A. Sanatkar, et al.
Published: (2025-01-01)

Effectiveness and safety of immunosuppressive regimens for adult idiopathic membranous nephropathy: network Meta-analysis
by: Zhou Ye-na, et al.
Published: (2021-01-01)

Tremors and Health-Related Quality of Life in Liver Transplant Recipients: Post-hoc Analysis of a Multicenter, Randomized, Controlled Trial Comparing a Life Cycle Pharma-Tacrolimus Regimen and Extended-Release Tacrolimus Regimen
by: M. B. Mulder, et al.
Published: (2025-04-01)